Viewing Study NCT05020769


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2025-12-25 @ 8:44 PM
Study NCT ID: NCT05020769
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2021-08-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module